LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_198253.2:c.2781A>G
TERT
· NP_937983.2:p.(Leu927=)
· NM_198253.2
GRCh37: chr5:1264581 T>C
·
GRCh38: chr5:1264466 T>C
Gene:
TERT
Transcript:
NM_198253.2
Final call
VUS
PM2 supporting
BP7 supporting benign
Variant details
Gene
TERT
Transcript
NM_198253.2
Protein
NP_937983.2:p.(Leu927=)
gnomAD AF
1.4872450149406155e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
NM_198253.2:c.2781A>G (p.Leu927=) in TERT is a synonymous variant with extremely low population frequency (gnomAD v4.1 AF = 0.00149%, 24/1,613,722 alleles; absent from gnomAD v2.1), meeting PM2 at supporting strength.
2
SpliceAI predicts no splicing alteration (max delta = 0.00), consistent with a silent variant, meeting BP7 at supporting_benign strength.
3
PVS1 is not met as this synonymous variant does not qualify as a null variant per the ClinGen SVI PVS1 decision framework (PMC6185798). Computational evidence is insufficient for PP3 or BP4. No variant-specific functional studies, case-control data, segregation data, or de novo observations are available. ClinVar reports mixed classifications (Uncertain significance, Likely benign, Benign) from single submitters without expert panel consensus.
4
With one supporting pathogenic criterion (PM2) and one supporting benign criterion (BP7), the net evidence weight is indeterminate. This variant is classified as a Variant of Uncertain Significance.
Final determination:
Generic ACMG/AMP 2015 fallback rules do not meet benign, likely benign, likely pathogenic, or pathogenic combination thresholds, so the variant is classified as Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | NM_198253.2:c.2781A>G is a synonymous variant (p.Leu927=) that does not fall into the PVS1 null-variant buckets of nonsense, frameshift, or canonical ±1,2 splice consensus variants per the ClinGen SVI PVS1 framework (PMC6185798). |
pvs1_generic_framework
|
| PS1 | N/A | Synonymous variant with no amino acid change; PS1 requires a different nucleotide change producing the same amino acid change as an established pathogenic variant. |
|
| PS2 | Not assessed | No de novo observation with confirmed paternity and maternity has been reported for this variant. |
|
| PS3 | Not assessed | No well-established in vitro or in vivo functional studies supporting a damaging effect have been identified for this specific synonymous variant. |
|
| PS4 | Not met | No case-control data demonstrate significantly increased prevalence of this variant in affected individuals. ClinVar-associated PMIDs (20301408, 20301779, 26389258, 26389333) are GeneReviews/PDQ summaries that do not mention this specific variant. |
clinvar
|
| PS5 | Not met | No reputable source has recently reported this variant as pathogenic. ClinVar aggregate classification is Uncertain significance with mixed submissions (2 US, 2 LB, 1 B); no expert panel consensus exists. |
clinvar
|
| PM1 | Not met | This variant does not lie in a statistically significant mutational hotspot per hotspot analysis, and no critical functional domain has been specifically implicated at codon 927. |
|
| PM2 | Met | This variant is extremely rare in population databases, with an allele frequency of 0.00149% (24/1,613,722 alleles) in gnomAD v4.1 and absent from gnomAD v2.1, well below the 0.1% PM2 threshold. |
gnomad_v4
gnomad_v2
|
| PM5 | N/A | Synonymous variant with no amino acid change; cannot evaluate same-residue pathogenic missense comparator per PM5 semantics. |
|
| PM6 | Not assessed | No de novo observation (with or without confirmed paternity) has been reported for this variant. |
|
| PP1 | Not assessed | No co-segregation data with disease in multiple affected family members has been reported for this variant. |
|
| PP2 | N/A | PP2 is specific to missense variants in genes with a low rate of benign missense variation. NM_198253.2:c.2781A>G is a synonymous (silent) variant, not a missense change. |
|
| PP3 | Not met | Multiple lines of computational evidence do not support a deleterious effect. SpliceAI predicts no splicing impact (max delta = 0.00). REVEL, BayesDel, and HCI prior scores are unavailable for this variant. |
spliceai
|
| PP4 | Not assessed | No patient phenotype or family history data are available to determine whether the clinical presentation is highly specific for a TERT-associated disorder. |
|
| PP5 | Not met | Of the four ClinVar-associated PMIDs flagged as PP5 candidates (GeneReviews/PDQ summaries: 20301408, 20301779, 26389258, 26389333), none mention NM_198253.2:c.2781A>G. These are gene-level reviews of TERT-associated disorders and do not constitute variant-specific evidence. |
clinvar
|
| BA1 | Not met | The population allele frequency of 0.00149% in gnomAD v4.1 is far below the 1% BA1 threshold. |
gnomad_v4
|
| BS1 | Not met | The population allele frequency of 0.00149% in gnomAD v4.1 is far below the 0.3% BS1 threshold. |
gnomad_v4
|
| BS2 | Not met | No homozygotes have been observed in gnomAD v4.1 (24 heterozygous alleles among 1,613,722 total alleles), failing to meet the requirement for observation in a healthy adult homozygous state. |
gnomad_v4
|
| BS3 | Not assessed | No well-established in vitro or in vivo functional studies demonstrating no damaging effect have been identified for this specific synonymous variant. |
|
| BS4 | Not assessed | No family segregation data are available to evaluate lack of segregation with disease. |
|
| BP1 | N/A | BP1 is specific to missense variants in genes where truncating variants are the primary disease mechanism. NM_198253.2:c.2781A>G is a synonymous variant, not a missense change. |
|
| BP2 | Not assessed | No data on observation in trans with a dominant pathogenic variant are available. |
|
| BP4 | Not met | Insufficient computational evidence to meet the 'multiple lines' threshold. SpliceAI predicts no splicing impact (delta = 0.00), but REVEL, BayesDel, and nucleotide conservation scores are unavailable for this variant. |
spliceai
|
| BP5 | Not assessed | No data on observation in a case with an alternate molecular basis for disease are available. |
|
| BP6 | Not met | ClinVar contains one benign and two likely benign single-submitter classifications, but these lack expert panel review or a published assertion from a reputable source with unavailable supporting evidence. |
clinvar
|
| BP7 | Met | NM_198253.2:c.2781A>G is a synonymous variant (p.Leu927=). SpliceAI predicts no impact on splicing with a maximum delta score of 0.00, consistent with a silent variant unlikely to alter gene product or splicing. |
spliceai
|
| BP3 | N/A | Skipped per directive; this variant is a substitution, not an in-frame indel in a repetitive region. |
|
| PM3 | N/A | Skipped per directive; TERT-associated disorders follow autosomal dominant or autosomal recessive inheritance patterns requiring specific trans/phase data not available for this assessment. |
|
| PM4 | N/A | Skipped per directive; this variant is a single-nucleotide substitution, not a protein-length-altering change. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.